The Fred Report - Weekly May 31, 2022

View a Printer Friendly version of this page, allowing you to print the page.

There was enough momentum on the downside so that this should have a retest – and this sort of formation should have the retest by the end of June.  One concern about this rally is that call premiums are really high, suggesting a near term pullback, and SPY could easily pull back to 404 to 405, before having another surge.  Biotechs are the most interesting speculation in this area and may indeed be the most interesting speculation for the remainder of 2022 and into 2023.



Sorry this page is available to subscribers only.
If you're not a subscriber why not join today?

If you are already a subscriber, please login.

If you believe you should be able to view this area, then please contact us and we will try to rectify this issue as soon as possible.


To gain access to the members only content click here to subscribe.

You will be given immediate access to premium content on the site.

 

 

 

Who is Fred Meissner, CMT?
Listen here:

The FRED Report is not authorized, endorsed, or affiliated with the Federal Reserve of St Louis and its FRED Economic Data.